• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非甾体抗炎药(NSAID)诱导的胃和小肠黏膜损伤的病理生理学。

The pathophysiology of non-steroidal anti-inflammatory drug (NSAID)-induced mucosal injuries in stomach and small intestine.

机构信息

Graduate School of Comprehensive Human Sciences, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki 305-8575, Japan.

出版信息

J Clin Biochem Nutr. 2011 Mar;48(2):107-11. doi: 10.3164/jcbn.10-79. Epub 2011 Feb 26.

DOI:10.3164/jcbn.10-79
PMID:21373261
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3045681/
Abstract

Non-steroidal anti-inflammatory drugs are the most commonly prescribed drugs for arthritis, inflammation, and cardiovascular protection. However, they cause gastrointestinal complications. The pathophysiology of these complications has mostly been ascribed to non-steroidal anti-inflammatory drugs' action on the cyclooxygenase inhibition and the subsequent prostaglandin deficiency. However, recent clinical demonstrated the prevalence of non-steroidal anti-inflammatory drugs-induced small intestinal mucosal injury is more often than previously expected. In this review, we discuss the defense mechanisms of stomach, and the pathophysiology of non-steroidal anti-inflammatory drugs-induced injury of stomach and small intestine, especially focused on non-steroidal anti-inflammatory drugs' action on mitochondria.

摘要

非甾体抗炎药是最常用于治疗关节炎、炎症和心血管保护的药物。然而,它们会引起胃肠道并发症。这些并发症的病理生理学主要归因于非甾体抗炎药对环氧化酶的抑制作用以及随后的前列腺素缺乏。然而,最近的临床研究表明,非甾体抗炎药引起的小肠黏膜损伤比以前预期的更为常见。在这篇综述中,我们讨论了胃的防御机制,以及非甾体抗炎药引起的胃和小肠损伤的病理生理学,特别是重点讨论了非甾体抗炎药对线粒体的作用。

相似文献

1
The pathophysiology of non-steroidal anti-inflammatory drug (NSAID)-induced mucosal injuries in stomach and small intestine.非甾体抗炎药(NSAID)诱导的胃和小肠黏膜损伤的病理生理学。
J Clin Biochem Nutr. 2011 Mar;48(2):107-11. doi: 10.3164/jcbn.10-79. Epub 2011 Feb 26.
2
The role of mitochondria-derived reactive oxygen species in the pathogenesis of non-steroidal anti-inflammatory drug-induced small intestinal injury.线粒体衍生的活性氧在非甾体抗炎药诱导的小肠损伤发病机制中的作用。
Free Radic Res. 2014 Sep;48(9):1095-9. doi: 10.3109/10715762.2014.928411. Epub 2014 Jul 21.
3
Rebamipide attenuates nonsteroidal anti-inflammatory drugs (NSAID) induced lipid peroxidation by the manganese superoxide dismutase (MnSOD) overexpression in gastrointestinal epithelial cells.雷贝拉唑通过胃肠道上皮细胞中超氧化物歧化酶(MnSOD)的过表达来减轻非甾体类抗炎药(NSAID)引起的脂质过氧化。
J Physiol Pharmacol. 2012 Apr;63(2):137-42.
4
[Recommendation for the prevention and treatment of non-steroidal anti-inflammatory drug-induced gastrointestinal ulcers and its complications].[非甾体抗炎药所致胃肠道溃疡及其并发症的防治建议]
Zhonghua Nei Ke Za Zhi. 2017 Jan 1;56(1):81-85. doi: 10.3760/cma.j.issn.0578-1426.2017.01.021.
5
The impact of non-steroidal anti-inflammatory drugs on the small intestinal epithelium.非甾体抗炎药对小肠上皮的影响。
J Clin Biochem Nutr. 2014 Jan;54(1):2-6. doi: 10.3164/jcbn.13-84. Epub 2013 Dec 18.
6
Gastroprotective and ulcer healing effects of nitric oxide-releasing non-steroidal anti-inflammatory drugs.释放一氧化氮的非甾体抗炎药的胃保护和溃疡愈合作用
Dig Liver Dis. 2000 Oct;32(7):583-94. doi: 10.1016/s1590-8658(00)80840-3.
7
Gastrointestinal mucosal injury following repeated daily oral administration of conventional formulations of indometacin and other non-steroidal anti-inflammatory drugs to pigs: a model for human gastrointestinal disease.对猪每日重复口服吲哚美辛及其他非甾体抗炎药的常规制剂后胃肠道黏膜损伤:一种人类胃肠道疾病模型
J Pharm Pharmacol. 2003 May;55(5):661-8. doi: 10.1211/002235703765344577.
8
Non-steroidal anti-inflammatory drug gastropathy: causes and treatment.非甾体抗炎药所致胃病:病因与治疗
Scand J Gastroenterol Suppl. 1996;220:124-7. doi: 10.3109/00365529609094763.
9
Bisphosphonate-induced gastrointestinal mucosal injury is mediated by mitochondrial superoxide production and lipid peroxidation.双膦酸盐诱导的胃肠道黏膜损伤是由线粒体超氧化物产生和脂质过氧化介导的。
J Clin Biochem Nutr. 2012 Nov;51(3):196-203. doi: 10.3164/jcbn.12-41. Epub 2012 Sep 5.
10
Microbiota Plays a Key Role in Non-Steroidal Anti-Inflammatory Drug-Induced Small Intestinal Damage.微生物群在非甾体抗炎药引起的小肠损伤中起关键作用。
Digestion. 2017;95(1):22-28. doi: 10.1159/000452356. Epub 2017 Jan 5.

引用本文的文献

1
Ketoprofen Lysine Salt vs. Ketoprofen Acid: Assessing the Evidence for Enhanced Safety and Efficacy.酮洛芬赖氨酸盐与酮洛芬酸:评估安全性和疗效增强的证据
Life (Basel). 2025 Apr 16;15(4):659. doi: 10.3390/life15040659.
2
Unexplained Gastric Ulcer: Role of Cinacalcet.不明原因胃溃疡:西那卡塞的作用
Cureus. 2025 Mar 7;17(3):e80226. doi: 10.7759/cureus.80226. eCollection 2025 Mar.
3
Evaluation of cats treated with robenacoxib after gastrointestinal surgery.罗非昔布治疗胃肠道手术后猫的评估。

本文引用的文献

1
Correlation of heat shock protein expression to gender difference in development of stress-induced gastric mucosal injury in rats.热休克蛋白表达与应激性胃黏膜损伤发展中性别差异的相关性研究。
J Clin Biochem Nutr. 2010 Jul;47(1):64-73. doi: 10.3164/jcbn.10-32. Epub 2010 May 26.
2
Gastroduodenal mucosal injury in patients taking low-dose aspirin and the role of gastric mucoprotective drugs: possible effect of rebamipide.在服用小剂量阿司匹林的患者中,胃十二指肠黏膜损伤和胃黏膜保护药物的作用:可能的瑞巴派特的作用。
J Clin Biochem Nutr. 2010 Jul;47(1):27-31. doi: 10.3164/jcbn.09-103. Epub 2010 Jun 17.
3
Preliminary trial of rebamipide for prevention of low-dose aspirin-induced gastric injury in healthy subjects: a randomized, double-blind, placebo-controlled, cross-over study.
J Feline Med Surg. 2024 Nov;26(11):1098612X241277024. doi: 10.1177/1098612X241277024.
4
Elevated risk of adverse effects from foodborne contaminants and drugs in inflammatory bowel disease: a review.炎症性肠病患者食用食物污染物和药物的不良反应风险升高:综述
Arch Toxicol. 2024 Nov;98(11):3519-3541. doi: 10.1007/s00204-024-03844-w. Epub 2024 Sep 9.
5
Apigenin attenuates indomethacin-induced gastric ulcer in rats: emphasis on antioxidant, anti-inflammatory, anti-apoptotic, and TGF-β1 enhancing activities.芹菜素减轻大鼠吲哚美辛诱导的胃溃疡:强调抗氧化、抗炎、抗凋亡和 TGF-β1 增强活性。
Naunyn Schmiedebergs Arch Pharmacol. 2024 Nov;397(11):8803-8814. doi: 10.1007/s00210-024-03200-w. Epub 2024 Jun 6.
6
Safety of Non-steroidal Anti-inflammatory Drugs as Part of Enhanced Recovery After Laparoscopic Sleeve Gastrectomy-A Systematic Review and Meta-Analysis.非甾体抗炎药在腹腔镜袖状胃切除术后加速康复中的安全性:系统评价和荟萃分析。
Obes Surg. 2024 Feb;34(2):643-652. doi: 10.1007/s11695-023-06984-7. Epub 2023 Dec 14.
7
Hydrogen Sulfide-Releasing Indomethacin-Derivative (ATB-344) Prevents the Development of Oxidative Gastric Mucosal Injuries.硫化氢释放型吲哚美辛衍生物(ATB-344)可预防氧化性胃黏膜损伤的发生。
Antioxidants (Basel). 2023 Aug 2;12(8):1545. doi: 10.3390/antiox12081545.
8
Potential pitfalls in reporting non-neoplastic gastrointestinal mucosal biopsies.非肿瘤性胃肠道黏膜活检报告中的潜在陷阱。
Histol Histopathol. 2023 Dec;38(12):1359-1372. doi: 10.14670/HH-18-632. Epub 2023 May 24.
9
Prevalence and pattern of multimorbidity among chronic kidney disease patients: a community study in chronic kidney disease hotspot area of Eastern India.慢性肾病患者中多重疾病的患病率及模式:印度东部慢性肾病热点地区的一项社区研究
Front Med (Lausanne). 2023 May 12;10:1131900. doi: 10.3389/fmed.2023.1131900. eCollection 2023.
10
The Clinical Pharmacology and Therapeutic Evaluation of Non-Steroidal Anti-Inflammatory Drugs in Adult Horses.成年马非甾体抗炎药的临床药理学与治疗评估
Animals (Basel). 2023 May 10;13(10):1597. doi: 10.3390/ani13101597.
雷贝拉唑预防健康受试者小剂量阿司匹林性胃损伤的初步临床试验:一项随机、双盲、安慰剂对照、交叉研究。
J Clin Biochem Nutr. 2009 Sep;45(2):248-53. doi: 10.3164/jcbn.09-24. Epub 2009 Aug 28.
4
Prevention of NSAID-Induced Small Intestinal Mucosal Injury: Prophylactic Potential of Lansoprazole.预防 NSAID 诱导的小肠黏膜损伤:兰索拉唑的预防潜力。
J Clin Biochem Nutr. 2009 Sep;45(2):125-30. doi: 10.3164/jcbn.SR09-58. Epub 2009 Aug 28.
5
Present status and strategy of NSAIDs-induced small bowel injury.非甾体抗炎药诱导的小肠损伤的现状与策略。
J Gastroenterol. 2009;44(9):879-88. doi: 10.1007/s00535-009-0102-2. Epub 2009 Jul 1.
6
Involvement of reactive oxygen species in indomethacin-induced apoptosis of small intestinal epithelial cells.活性氧在吲哚美辛诱导的小肠上皮细胞凋亡中的作用。
J Gastroenterol. 2009;44 Suppl 19:30-4. doi: 10.1007/s00535-008-2293-3. Epub 2009 Jan 16.
7
Gastric mucosal defense and cytoprotection: bench to bedside.胃黏膜防御与细胞保护:从 bench 到 bedside。 (注:bench 通常指实验室研究阶段,bedside 通常指临床应用阶段,这里意译为从基础研究到临床实践)
Gastroenterology. 2008 Jul;135(1):41-60. doi: 10.1053/j.gastro.2008.05.030. Epub 2008 Jun 10.
8
Lansoprazole protects and heals gastric mucosa from non-steroidal anti-inflammatory drug (NSAID)-induced gastropathy by inhibiting mitochondrial as well as Fas-mediated death pathways with concurrent induction of mucosal cell renewal.兰索拉唑通过抑制线粒体以及Fas介导的死亡途径,并同时诱导黏膜细胞更新,来保护和修复胃黏膜免受非甾体抗炎药(NSAID)引起的胃病。
J Biol Chem. 2008 May 23;283(21):14391-401. doi: 10.1074/jbc.M800414200. Epub 2008 Mar 28.
9
Mitochondria, oxidative stress and cell death.线粒体、氧化应激与细胞死亡。
Apoptosis. 2007 May;12(5):913-22. doi: 10.1007/s10495-007-0756-2.
10
Rebamipide significantly inhibits indomethacin-induced mitochondrial damage, lipid peroxidation, and apoptosis in gastric epithelial RGM-1 cells.瑞巴派特显著抑制吲哚美辛诱导的胃上皮RGM-1细胞的线粒体损伤、脂质过氧化和细胞凋亡。
Dig Dis Sci. 2005 Oct;50 Suppl 1:S76-83. doi: 10.1007/s10620-005-2810-7.